Beclason ECO Easy Breathe: new possibilities of known drug in treatment of asthma
https://doi.org/10.18093/0869-0189-2005-0-1-66-72
Abstract
An open comparative trial was designed to compare clinical efficacy of beclomethasone dipropionate (BDP) via non-freon metered dose inhaler (MDI) Easy Breathe or freon-containing MDI.
The trial involved 30 patients not younger than 18 yrs with stable moderate to severe bronchial asthma (BA). The length of the disease exceeded 12 months and duration of previous therapy with inhaled steroids (freon-containing BDP) 1 000 to 1 500 mcg daily was at least 4 months. The trial duration was 6 months. The patients were randomised into 2 groups, 15 patients in each. Clinical signs, peak expiratory flow rate, need in short-acting β2-agonists were monitored. The study group patients were given non-freon BDP (Easy Breathe) instead of freon-containing BDP in the ratio 1 : 1. The control group patients continued treatment with freon-containing BDP. Then BDP daily doses were gradually reduced in both the groups while BA was controlled adequately. The daily dose was reduced by 500 mcg in average in 11 of 15 (73.3 %) non-freon BDP patients and in 6 (40 %) freon-containing BPD patients.
So, BDP via MDI ECO Easy Breathe allows moderate to severe BA to be controlled with lower doses of the drug. This reduces a cost of the therapy, rate of potential adverse effects and results in improvement of quality of life of the patients.
About the Authors
A. I. Sinopalnikov
Государственный институт усовершенствования врачей МО РФ
Russian Federation
Russian Federation
I. L. Klyachkina
Государственный институт усовершенствования врачей МО РФ
Russian Federation
Russian Federation
M. B. Mironov
Государственный институт усовершенствования врачей МО РФ
Russian Federation
Russian Federation
References
1. Бронхиальная астма. Глобальная стратегия. Национальный Институт Сердце, Легкие и Кровь. Издание № 95-3659. Январь 1995. Русская версия под ред. акад. А.Г.Чучалина. Пульмонология. 1996.
2. Чучалин А.Г., Медников Б.Л., Белевский А.С. и др. Бронхиальная астма. Руководство для врачей России. (Формулярная система). Пульмонология 1999; Прил.
3. Huchon G. Metered dose inhalers: past and present: advantages and limitations. Eur. Respir. Rev. 1997; 41: 26—28.
4. Chinet T., Huchon G. La mauvaise utilisation des aerosols-doseurs pressurises dans maladies bronchiques: frequence et consequence cliniques. Ann. Med. Int. 1994; 145: 119—124.
5. Goodman D.E., Israel E., Rosenberg M. et al. The influence of age, diagnosis and gender on proper use of metered-dose inhalers. Am. J. Respir. Care. Med. 1994; 150: 1256—1261.
6. Thompson J., Irvine T., Grathwohl K. et al. Misuse of metered-dose inhalers. Chest 1994; 105: 715—717.
7. Engel T., Heining J.H., Malling H.J. et al. Clinical comparison of inhaled budesonide delivered via pressurized metered-dose inhaler or Turbuhaler. Allergy 1989; 44: 220—225.
8. Огородова Л.М. Системы ингаляционной доставки препаратов в дыхательные пути. Пульмонология 1999; 1: 84—87.
9. Chuchalin A.G., Sakharova G.M. et al. Eur. Respir. J. 2000; 16 (suppl. 31): 316S.
10. Crompton G.K., Duncan J. Clinical assessment of a new breath-actuated inhaler. Practitioner 1989; 233: 268—269.
11. Anhoj J., Bisgaard H., Lipwort B.J. Effect of electrostatic charge in plastic spacers on the lung delivery of HFA-salbutamol in children. Br. J. Clin. Pharmacol. 1999; 47: 333—336.
12. Hardy J.G., Jasuja A.K., Trier M. et al. A small volume spacer for the use with a breath — operated pressurised metered dose inhaler. Int. J. Pharmaceut. 1996; 142: 129—133.
13. Newman S.P., Weisz A.W.B., Talace N. et al. Improvement of drug delivery with a breath actuated pressured aerosol for patients with poor inhaler technique. Thorax 1991; 46: 712—716.
14. Cochrane M.J., Mohan M.D., Bala V. et al. Inhaled corticosteroides for asthma therapy patient compliance, devices, and inhalation technique. Chest 2000; 117 (2): 542—550.
15. Lenney J., Innes J.A., Crompton G.K. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI. Respir. Med. 2000; 94: 496—500.
16. Brown H.V., Storey G., George W.H.S. Beclomethasone dipropionat: a new steroid aerosol for the treatment of allergic asthma. Br. Med. J. 1972; 1: 585—590.
17. Leach C.L. Improved thievery of inhaled steroids to the large and small airways. Respir. Med. 1998; 92 (suppl. A): 3—8.
18. Milanovski J., Qualthrough J., Perrin V.L. Inhaled beclometasone (BDP) with non-CFC propellant for the treatment of astma. Respir. Med. 1999; 93: 245—251.
19. Farmer L.S., Middle M., Savic J. et al. Therapeutic equivalence of inhaled beclometasone dipropionate with CFC and non- CFC (HFA 134a) propellants both delivered via the «Easybreathe» TM inhaler for the treatment of pediatric asthma. Respir. Med. 2000; 94: 57—63.
20. Busse W.W., Brazinsky S., Jacobson K. et al. Efficacy response of inhaled beclometasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. J. Allergy Clin. Immunol. 1999; 104 (6): 1215—1222.
Review
For citations:
Sinopalnikov A.I., Klyachkina I.L., Mironov M.B. Beclason ECO Easy Breathe: new possibilities of known drug in treatment of asthma. PULMONOLOGIYA. 2005;(1):66-72. (In Russ.) https://doi.org/10.18093/0869-0189-2005-0-1-66-72
Views:
491
Email this article 